| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.053 | 0.08 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.055 | 0.09 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.061 | 0.09 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.09 | 0.09 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.09 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.09 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.055 | 0.09 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.1 |